Table of Contents Table of Contents 2 List of Tables 3 List of Figures 3 Report Guidance 4 Clinical Trials by Region 5 Clinical Trials and Average Enrollment by Country 6 Top Countries Contributing to Clinical Trials in Asia-Pacific 8 Top Countries Contributing to Clinical Trials in Europe 9 Top Countries Contributing to Clinical Trials in North America 10 Top Countries Contributing to Clinical Trials in Middle East and Africa 11 Clinical Trials by G7 Countries: Proportion of Cerebral Aneurysms to Cardiovascular Clinical Trials 12 Clinical Trials by Phase in G7 Countries 13 Clinical Trials in G7 Countries by Trial Status 14 Clinical Trials by E7 Countries: Proportion of Cerebral Aneurysms to Cardiovascular Clinical Trials 15 Clinical Trials in E7 Countries by Trial Status 16 Clinical Trials by Phase 17 In Progress Trials by Phase 18 Clinical Trials by Trial Status 19 Clinical Trials by End Point Status 20 Subjects Recruited Over a Period of Time 21 Clinical Trials by Sponsor Type 22 Prominent Sponsors 23 Top Companies Participating in Cerebral Aneurysms Therapeutics Clinical Trials 24 Prominent Drugs 25 Clinical Trial Profile Snapshots 26 Appendix 35 Abbreviations 35 Definitions 35 Research Methodology 36 Secondary Research 36 About GlobalData 37 Contact Us 37 Disclaimer 37 Source 38

List of Tables Cerebral Aneurysms Therapeutics, Global, Clinical Trials by Region, 2016* 5 Cerebral Aneurysms Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6 Cerebral Aneurysms Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7 Cerebral Aneurysms Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016* 8 Cerebral Aneurysms Therapeutics Clinical Trials, Europe, Top Countries, 2016* 9 Cerebral Aneurysms Therapeutics Clinical Trials, North America, Top Countries, 2016* 10 Cerebral Aneurysms Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 11 Proportion of Cerebral Aneurysms to Cardiovascular Clinical Trials, G7 Countries (%), 2016* 12 Cerebral Aneurysms Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 13 Cerebral Aneurysms Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 14 Proportion of Cerebral Aneurysms to Cardiovascular Clinical Trials, E7 Countries (%), 2016* 15 Cerebral Aneurysms Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 16 Cerebral Aneurysms Therapeutics, Global, Clinical Trials by Phase, 2016* 17 Cerebral Aneurysms Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 18 Cerebral Aneurysms Therapeutics, Global, Clinical Trials by Trial Status, 2016* 19 Cerebral Aneurysms Therapeutics Clinical Trials, Global, by End Point Status, 2016* 20 Cerebral Aneurysms Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 21 Cerebral Aneurysms Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 22 Cerebral Aneurysms Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 23 Cerebral Aneurysms Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 24 Cerebral Aneurysms Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 25 List of Figures Cerebral Aneurysms Therapeutics, Global, Clinical Trials by Region (%), 2016* 5 Cerebral Aneurysms Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6 Cerebral Aneurysms Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7 Cerebral Aneurysms Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2016* 8 Cerebral Aneurysms Therapeutics Clinical Trials, Europe, Top Countries (%), 2016* 9 Cerebral Aneurysms Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 10 Proportion of Cerebral Aneurysms to Cardiovascular Clinical Trials, G7 Countries (%), 2016* 12 Cerebral Aneurysms Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 13 Cerebral Aneurysms Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 14 Proportion of Cerebral Aneurysms to Cardiovascular Clinical Trials, E7 Countries (%), 2016* 15 Cerebral Aneurysms Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 16 Cerebral Aneurysms Therapeutics, Global, Clinical Trials by Phase (%), 2016* 17 Cerebral Aneurysms Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 18 Cerebral Aneurysms Therapeutics, Global, Clinical Trials by Trial Status, 2016* 19 Cerebral Aneurysms Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 21 Cerebral Aneurysms Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 22 Cerebral Aneurysms Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 23 Cerebral Aneurysms Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 24 Cerebral Aneurysms Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 25 GlobalData Methodology 36

Hope Pharmaceuticals, Inc. Medpace, Inc. Edge Therapeutics, Inc.